Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 1, 2021
- Accepted in final form September 14, 2021
- First Published November 10, 2021.
Author Disclosures
- Gemma Olivé-Cirera, MD (olive.cirera.gemma{at}gmail.com),
- Elianet Fonseca, MD (elianet.fonsec{at}gmail.com),
- Verónica Cantarín-Extremera, MD (veronica.cantarin{at}salud.madrid.org),
- María Vázquez-López, MD (maria.vazquez{at}salud.madrid.org),
- María Jiménez-Legido, MD (mjimenezl{at}salud.madrid.org),
- Verónica González-Álvarez, MD (vgonzalez{at}sjdhospitalbarcelona.org),
- Juliana Ribeiro-Constante, MD (jribeiroconstante{at}gmail.com),
- Ana Camacho-Salas, MD (acamachosalas{at}yahoo.es),
- Itxaso Martí, MD (itxasomarti{at}gmail.com),
- Ramon Cancho-Candela, MD (rcanchoc{at}saludcastillayleon.es),
- María Jesús Martínez-González, MD (mariajesus.martinezgonzalez{at}osakidetza.eus),
- Albert Saiz, MD, PhD (asaiz{at}clinic.cat) and
- Thaís Armangué, MD, PhD
- on behalf of the Spanish Study Group NeuroimmunoPed-Covid
- Gemma Olivé-Cirera, MD (olive.cirera.gemma{at}gmail.com),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
INVEST-AEP fellowship 2019 of the Pediatric Spanish Society
NONE
NONE
NONE
NONE
NONE
NONE
- Elianet Fonseca, MD (elianet.fonsec{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Verónica Cantarín-Extremera, MD (veronica.cantarin{at}salud.madrid.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- María Vázquez-López, MD (maria.vazquez{at}salud.madrid.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- María Jiménez-Legido, MD (mjimenezl{at}salud.madrid.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Verónica González-Álvarez, MD (vgonzalez{at}sjdhospitalbarcelona.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Juliana Ribeiro-Constante, MD (jribeiroconstante{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ana Camacho-Salas, MD (acamachosalas{at}yahoo.es),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Itxaso Martí, MD (itxasomarti{at}gmail.com),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Basque regional goverment from Spain. Grant : 20BU211: Creation of a virtual reality program for the EEG. 15000 Euros. 2020-2022. Principal investigator.
Basque University( UPV/ EHU). GIU20/057, Grant of 38.720 Euros as a grant for research teams in the university. Neuroscience group. I do not receive direct compensation from this grant
None
NONE
NONE
NONE
NONE
NONE
NONE
- Ramon Cancho-Candela, MD (rcanchoc{at}saludcastillayleon.es),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- María Jesús Martínez-González, MD (mariajesus.martinezgonzalez{at}osakidetza.eus),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Albert Saiz, MD, PhD (asaiz{at}clinic.cat) and
NONE
NONE
compensation for consulting services and speaker honoraria from Bayer-Schering, Merck-Serono, Biogen-Idec, Sanofi-Aventis, Teva Pharmaceutical Industries Ltd, Novartis, Alexion,and Roche
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thaís Armangué, MD, PhD
None
NONE
I received speaker honnoraria from Novartis, Biogen and Sanofi-Aventis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I received research support from Instituto Carlos III (PI18/00486 and PI21/00316), and Govern de la Generalitat de Catalunya (SLT006/17/00362)
NONE
I received research support from Mutua Madrilena Fundation AP162572016 and La Marato de TV3 foundation (37/C/2021), Torrons Vicens Foundation grant (PFNR0144), Pablove Foundation (pC ID): 689368), and 2021 Invest AEP Grant
NONE
NONE
NONE
NONE
NONE
NONE
- From the Pediatric Neuroimmunology Program (G.O.-C.,E.F.,A.S.,T.A.), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Hospital Clinic, University of Barcelona; Pediatric Neurology Unit of Parc Taulí Hospital of Sabadell (G.O.-C.), Barcelona; Pediatric Neurology Unit of Hospital Infantil Universitario Niño Jesús (V.C.-E.,M.J.-L.), Madrid; Pediatric Neurology Unit of Hospital Gregorio Marañón (M.V.-L.), Madrid; Pediatric Neuroimmunology Unit (V.G.-A.,J.R.-C.,T.A.), Neurology Service, Sant Joan de Déu (SJD) Children's Hospital, University of Barcelona; Pediatric Neurology Unit of Hospital Universitario 12 de Octubre, Complutense University of Madrid (A.C.S.); Pediatric Neurology Unit of Hospital Universitario Donostia (I.M.), Guipuzcoa; Pediatric Neurology Unit of Hospital Universitario Río Hortega (R.C.-C.), Valladolid; and Pediatric Neurology Unit of Cruces University Hospital (M.J.M.-G.), Bilbao, Spain.
- Correspondence
Dr. Armangué armangue{at}clinic.cat
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.